Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


White Meets Blue - Enzymicals AG and the Institute of Marine Biotechnologye.V. start to cooperate

The Enzymicals AG, an emerging company in the field of industrial (white) biotechnology, and the Institute of Marine Biotechnology e.V. (IMaB), an association in the area of marine (blue) biotechnology, have signed a comprehensive agreement to cooperate in the future.The two institutions both located in Greifswald, Germany, combine thereby their competencies in the commercialization of alternative expression systems and functional genome analysisfor the production of fine chemicals.

The signed contract includes the joint use of innovative technologies for the identification and production of novel enzymes from aquatic sources,amongst others. “Dormant potentials of marine habitats for biotransformations can be deciphered and brought into market by the focused application of proteomics-based biotechnology”, says Prof. Dr. Thomas Schweder of the IMaB. ”Together with Enzymicals AG, we can offer our expertise in the field of de novo genome sequencing and gene annotation to a wide audience as a service.”

Thewhole value chain can be covered jointly by merchandising of new biocatalysts from aquatic systems and the application-oriented process development by Enzymicals AG.

The two institutionscomplement each other in their strategic alignment perfectly by the construction of expression systems and production strains for applications in fine chemistry.

“Thus, our customers will gain access to exquisite biocatalysts for applications in the chemical and pharmaceutical industry”, adds Dr. Ulf Menyes, CEO of Enzymicals AG, who foresees a strengthening of core competencies by the partnership.

Both new and existing customers will gain a long-term competitive advantage in tailored product and process development based on innovative biocatalysts from the cooperation of both institutions.

About Enzymicals AG:
The Enzymicals AG, Greifswald, was founded as a start-up company in August 2009, initialized by the workgroup of Prof. UweBornscheuer, Institute of Biochemistry at the University of Greifswald. The company specializes in enzymatic reactions for the production of fine and specialty chemicals and the manufacture and sale of biocatalysts.

The interdisciplinary team of biochemists, biologists, synthetic and process chemists is led by Dr. Ulf Menyes (chemist) as chief executive officer (CEO) and Dr. Rainer Wardenga (biologist) as head of research and production (CSO). The Enzymicals AG has establishedcollaborations with leading companies in the chemical industry and established the technical requirements for the production of enzymes and for the biotechnological synthesis of specialty and fine chemicals on kg-scalewithin a short period of time. Enzymicals is member of BioCon Valley MV e.V.

About the Institute of Marine Biotechnologye.V.:
The Institute of Marine Biotechnology e.V. (IMaB) was founded in 1996. The main concern of the institute is to promote and develop research in the field of marine biotechnology. This is done in close cooperation with the Ernst-Moritz-ArndtUniversity of Greifswald. Research interests of the IMaB include the functional genome and proteome analysis of marine microorganisms, the discovery, enrichment and characterization of bioactive compounds from marine organisms and the development of new bacterial expression systems.

A particular focus is on the field of functional genomics of marine microorganisms. The increasing number of sequenced genomes of marine bacteria and the extensive data on marine metagenomes allow a comprehensive insight into the previously unknown metabolic activities of marine organisms. The functional genome analysis is substantially supported by the analysis of the physiological proteome. One of the most modern and best equipped proteome centers in Germany was established at the University of Greifswald in recent years. These technologies are used by the IMaB to determine relevant, new gene functions and to make them accessible for biotechnological applications. The Institute is member of BioCon Valley MV e.V.

Enzymicals AG
Dr. Ulf Menyes, CEO
Walther-Rathenau-Str. 49a
17489 Greifswald, Germany
Tel.: +49-3834-515 470
Fax.: +49-3834-515 473
Institutfür Marine Biotechnologiee.V.
Prof. Dr. Thomas Schweder
Walther-Rathenau-Str. 49A
D-17489 Greifswald
Tel.: +49(0)3834 864212
Fax +49(0)3834 864238

Dr. Heinrich Cuypers | idw
Further information:

More articles from Life Sciences:

nachricht Sweetening neurotransmitter receptors and other neuronal proteins
28.10.2016 | Max-Planck-Institut für Hirnforschung

nachricht A new look at thyroid diseases
28.10.2016 | Jacobs University Bremen gGmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

How nanoscience will improve our health and lives in the coming years

27.10.2016 | Materials Sciences

OU-led team discovers rare, newborn tri-star system using ALMA

27.10.2016 | Physics and Astronomy

'Neighbor maps' reveal the genome's 3-D shape

27.10.2016 | Life Sciences

More VideoLinks >>>